Information  X 
Enter a valid email address

Permanent TSB Group (IL0A)

  Print   

Wednesday 12 August, 2020

Permanent TSB Group

Director/PDMR Shareholding

RNS Number : 9620V
Permanent TSB Group Holdings PLC
12 August 2020
 

NOTIFICATION OF DEALINGS

 

Permanent TSB Group Holdings plc (the "Company")

Notification of Transactions by Persons Discharging Managerial Responsibilities and Persons Closely Associated with them

 

 This form is required for disclosure of transactions under Article 19 of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (Market Abuse Regulation)

 

1

Details of the person discharging managerial responsibilities/person closely associated

 

a)

Name

 

Eamonn Crowley

 

 

 

 

2

Reason for the notification

 

a)

Position/status

Chief Executive Officer

 

 

 

 

 

 

b)

Initial Notification Amendment

Initial Notification

 

 

 

 

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Permanent TSB Group Holdings plc

 

b)

LEI

 

635400DTNHVYGZODKQ93

 

 

 

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial  instrument,

type  of

instrument

Identification code

 

Ordinary €0.50 shares each

ISIN: IE00BWB8X525

 

b)

Nature of the transaction 

 

Purchase of Shares

 

 

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

€0.4976

50,000

 

 

d)

Aggregated information

- Aggregated volume

- Price

 

50,000 shares @ €0.4976

e)

Date of the transaction

 

12 August 2020

f)

Place of the transaction

 

Euro-Next Dublin, Ireland

 

 

g)

Additional Information

 

 

 

 

 

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
DSHZLLFFBVLFBBX

a d v e r t i s e m e n t